Drug checking in the fentanyl era: Utilization and interest among people who inject drugs in San Diego, California

dc.contributor.authorBailey, Katie
dc.contributor.authorAbramovitz, Daniela
dc.contributor.authorArtamonova, Irina
dc.contributor.authorDavidson, Peter
dc.contributor.authorStamos-Buesig, Tara
dc.contributor.authorVera, Carlos F.
dc.contributor.authorPatterson, Thomas L.
dc.contributor.authorArredondo, Jaime
dc.contributor.authorKattan, Jessica
dc.contributor.authorBergmann, Luke
dc.contributor.authorThihalolipavan, Sayone
dc.contributor.authorStrathdee, Steffanie A.
dc.contributor.authorBorquez, Annick
dc.date.accessioned2023-11-07T22:08:29Z
dc.date.available2023-11-07T22:08:29Z
dc.date.copyright2023en_US
dc.date.issued2023
dc.description.abstractBackground In North America, overdose rates have steeply risen over the past five years, largely due to the ubiquity of illicitly manufactured fentanyls in the drug supply. Drug checking services (DCS) represent a promising harm reduction strategy and characterizing experiences of use and interest among people who inject drugs (PWID) is a priority. Methods Between February-October 2022, PWID participating in a cohort study in San Diego, CA and Tijuana, Mexico completed structured surveys including questions about DCS, socio-demographics and substance use behaviors. We used Poisson regression to assess factors associated with lifetime DCS use and characterized experiences with DCS and interest in free access to DCS. Results Of 426 PWID, 72% were male, 59% Latinx, 79% were experiencing homelessness and 56% ever experienced a nonfatal overdose. One third had heard of DCS, of whom 57% had ever used them. Among the latter, most (98%) reported using fentanyl test strips (FTS) the last time they used DCS; 66% did so less than once per month. In the last six months, respondents used FTS to check methamphetamine (48%), heroin (30%) or fentanyl (29%). Relative to White/non-Latinx PWID, those who were non-White/Latinx were significantly less likely to have used DCS [adjusted risk ratio (aRR): 0.22; 95% CI: 0.10, 0.47), as were PWID experiencing homelessness (aRR:0.45; 95% CI: 0.28, 0.72). However, a significant interaction indicated that non-White/Latinx syringe service program (SSP) clients were more likely to have used DCS than non-SSP clients (aRR: 2.79; CI: 1.09, 7.2). Among all PWID, 44% expressed interest in free access to FTS, while 84% (of 196 PWID) expressed interest in advanced spectrometry DCS to identify and quantify multiple substances. Conclusions Our findings highlight low rates of DCS awareness and utilization, inequities by race/ethnicity and housing situation, high interest in advanced spectrometry DCS versus FTS, and the potential role of SSPs in improving access to DCS, especially among racial/ethnic minorities.en_US
dc.description.reviewstatusRevieweden_US
dc.description.scholarlevelFacultyen_US
dc.description.sponsorshipThis work was supported by the National Institute on Drug Abuse [grant numbers R01DA049644, T32DA023356, DP2DA049295]. The sponsor(s) did not have any role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.en_US
dc.identifier.citationBailey, K., Abramovitz, D., Artamonova, I., Davidson, P., Stamos-Buesig, T., Vera, C. F., ... Borquez, A. (2023). Drug checking in the fentanyl era: Utilization and interest among people who inject drugs in San Diego, California. International Journal of Drug Policy, 118, 104086. https://doi.org/10.1016/j.drugpo.2023.104086en_US
dc.identifier.urihttps://doi.org/10.1016/j.drugpo.2023.104086
dc.identifier.urihttp://hdl.handle.net/1828/15600
dc.language.isoenen_US
dc.publisherInternational Journal of Drug Policyen_US
dc.subjectHarm reductionen_US
dc.subjectDrug checking servicesen_US
dc.subjectFentanyl test stripsen_US
dc.subjectSpectrometryen_US
dc.subjectSerive accessen_US
dc.titleDrug checking in the fentanyl era: Utilization and interest among people who inject drugs in San Diego, Californiaen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
bailey_katie_IntJDrugPolicy_2023.pdf
Size:
516.75 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2 KB
Format:
Item-specific license agreed upon to submission
Description: